SCHEMBL6350271

SCHEMBL6350271

COc1cc(C(=O)c2ccc(C(=O)Nc3ccc(Cl)cc3C(=O)O)cc2)cc(OC)c1OC

nearest known ligand 0.68

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 7/20 0.68
SMN1; SMN2 Q16637 2/20 0.57
LMNA P02545 1/20 0.57
MEN1 O00255 1/20 0.56
PKM P14618 1/20 0.56
KMT2A Q03164 1/20 0.56
NPSR1 Q6W5P4 1/20 0.56
ATM Q13315 1/20 0.55
ABL1 P00519 1/20 0.54
RIN1 Q13671 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
MAPT P10636 2/20 0.53
KCNK2 O95069 1/20 0.53
KCNK10 P57789 1/20 0.53
AKR1C4 P17516 1/20 0.52
AKR1C3 P42330 1/20 0.52
AKR1C2 P52895 1/20 0.52
AKR1C1 Q04828 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11233843 0.92 SERPINE1 (0.60) SERPINE1SMN1; SMN2LMNAMEN1PKM
SCHEMBL6352349 0.90 SERPINE1 (0.61) SERPINE1SMN1; SMN2LMNAMEN1KMT2A
SCHEMBL6351589 0.86 KMT2A (0.75) SERPINE1SMN1; SMN2LMNAMEN1PKM
SCHEMBL11231268 0.84 CHEK1 (0.70) SERPINE1MEN1PKMKMT2ANPSR1
SCHEMBL6358123 0.84 SERPINE1 (0.89) SERPINE1MEN1KMT2AMAPTKCNK2
SCHEMBL11228267 0.82 MEN1 (0.69) SMN1; SMN2LMNAMEN1PKMKMT2A
SCHEMBL11237527 0.82 HPGD (0.67) SMN1; SMN2LMNAMEN1KMT2AMAPT
SCHEMBL420616 0.81 SERPINE1 (1.00) SERPINE1LMNAMAPTKCNK2KCNK10
SCHEMBL6352878 0.80 SERPINE1 (0.76) SERPINE1MEN1PKMKMT2ANPSR1
SCHEMBL6353639 0.79 SERPINE1 (0.74) SERPINE1TDP1KCNK2KCNK10AKR1C4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 SERPINE1 1929/4885SMN1; SMN2 3015/4885LMNA 4552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.